Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.
Future Oncol
; 13(7): 603-613, 2017 Mar.
Article
em En
| MEDLINE
| ID: mdl-27842456
ABSTRACT
AIM:
To provide a multi-institutional description of current practices of stereotactic body radiotherapy (SBRT) for head and neck cancer. MATERIALS &METHODS:
15 international institutions with significant experience in head and neck SBRT were asked to complete a questionnaire covering clinical and technical factors.RESULTS:
SBRT is used 10-100% of the time for recurrent primary head and neck cancer, and 0-10% of the time in newly diagnosed disease. Five centers use a constraint for primary disease of 3-5 cm and 25-30 cc. Nine institutions apply a clinical target volume expansion of 1-10 mm and 14 use a planning target volume margin of 1-5 mm. Fractionation regimens vary between 15 and 22 Gy in 1 fraction to 30-50 Gy in 5 or 6 fractions. The risk of carotid blowout quoted in the re-irradiation setting ranges from 3 to 20%.CONCLUSION:
There is considerable heterogeneity in patient selection and techniques in head and neck SBRT practice among experienced centers.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Radiocirurgia
/
Pesquisas sobre Atenção à Saúde
/
Padrão de Cuidado
/
Neoplasias de Cabeça e Pescoço
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
Idioma:
En
Revista:
Future Oncol
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Canadá